Scientists develop vaccine strategy for peanut allergyBMJ 1999; 318 doi: http://dx.doi.org/10.1136/bmj.318.7188.894 (Published 03 April 1999) Cite this as: BMJ 1999;318:894
- Scott Gottlieb
- New York
Researchers believe that they may be close to developing a new strategy to combat anaphylactic allergies-such as the increasingly common allergy to peanuts-in which doctors induce tolerance using an oral formulation containing a gene from the offending allergen.
Many established allergies have been traditionally treated by immunotherapy, in which subcutaneous injections of progressively increasing doses of purified allergen are given; a strategy that is effective only in some circumstances. Dr Kam Leong, professor of biomedical engineering at …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial